Sign inOpen the app
Infectious Disease Puscast

Infectious Disease Puscast #42

Nov 28, 2023 · 36 min · Episode 42 · 26.5 MB
0:00-36:30

Streams straight from the publisher. podnod never proxies or re-hosts episode audio.

Open in podnod

On episode #42 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 11/09 – 11/21/23.

Host: Daniel Griffin and Sara Dong

Subscribe (free): Apple Podcasts, RSS, email

Become a patron of Puscast!

Links for this episode
  • Progress toward measles elimination (CDC)
  • Slaying the troll of transplantation (TID)
  • Association between the neutrophil-to-lymphocyte ratio and adverse outcomes in children aged
  • Pre-exposure prophylaxis use history in people with antiretroviral resistance at HIV diagnosis (CID)
  • Impact of the 2019 FDA guidance for uncomplicated UTI on treatment response rates (OFID)
  • CDC Guidelines for the prevention and treatment of anthrax (CDC)
  • Contemporary use of cefazolin for MSSA infective endocarditis (IJID)
  • Is carbapenem therapy necessary for treatment of non-CTX-M ESBL-producing Enterobacterales bloodstream infections (CID)
  • Infectious diseases consultation associated with reduced mortality in gram-negative Bacteremia (CID)
  • Contemporary management of Staphylococcus aureus bacteremia (CID)
  • Tuning sterol extraction kinetics yields a renal-sparing polyene antifungal (Nature)
  • Impact of in-house Candida auris PCR screening on admission on the incidence rates of surveillance and blood cultures with C. auris and associated cost savings (OFID)
  • Human lobomycosis caused by Paracoccidioides loboi (EID)
  • Molecular surveillance detects high prevalence of the neglected parasite Mansonella ozzardi (JID)
  • Efficacy and safety of moxidectin compared with ivermectin against Strongyloides stercoralis infection in adults (The Lancet)
  • Efficacy of bortezomib for treating anti-interferon-gamma autoantibody-associated adult-onset immunodeficiency (AOID) syndrome (CID)
  • Investigational non-antibiotic therapeutics for infections in hematopoietic cell transplant recipients and patients with hematologic malignancies receiving cellular therapies (TID)
  • Black box warning: large language models and the future of infectious diseases consultations (CID)

Music is by Ronald Jenkees